Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingbin Cui

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Chemical Biology & Drug Design|March 4, 2014
Design, synthesis, and preliminary cardioprotective effect evaluation of danshensu derivativesQingbin Cui, Yonghong Chen, Mingjuan Zhang, et al.
International Journal of Molecular Sciences|March 6, 2021
The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 TransporterSilpa Narayanan, Nehaben A Gujarati, Jing-Quan Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 1, 2019
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistanceSilpa Narayanan, Chao-Yun Cai, Yehuda G Assaraf, et al.
Frontiers in Cell and Developmental Biology|December 28, 2020
Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase InhibitorJing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, et al.
Cancers|February 23, 2020
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer CellsJing-Quan Wang, Jonathan Y Li, Qiu-Xu Teng, et al.
Frontiers in Oncology|July 17, 2020
Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer CellsWeiguo Feng, Meng Zhang, Zhuo-Xun Wu, et al.
Frontiers in Oncology|July 6, 2019
Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an <i>in vitro</i> StudyNing Ji, Yuqi Yang, Chao-Yun Cai, et al.
Frontiers in Oncology|August 15, 2020
NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug ResistanceMeng Zhang, Xuan-Yu Chen, Xing-Duo Dong, et al.
Cancer Communications (London, England)|June 12, 2020
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitorYuqi Yang, Ning Ji, Chao-Yun Cai, et al.
Frontiers in Pharmacology|March 14, 2022
Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer CellsXing-Duo Dong, Meng Zhang, Chao-Yun Cai, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Chemical Biology & Drug Design|March 4, 2014
Design, synthesis, and preliminary cardioprotective effect evaluation of danshensu derivativesQingbin Cui, Yonghong Chen, Mingjuan Zhang, et al.
International Journal of Molecular Sciences|March 6, 2021
The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 TransporterSilpa Narayanan, Nehaben A Gujarati, Jing-Quan Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 1, 2019
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistanceSilpa Narayanan, Chao-Yun Cai, Yehuda G Assaraf, et al.
Frontiers in Cell and Developmental Biology|December 28, 2020
Reversal of Cancer Multidrug Resistance (MDR) Mediated by ATP-Binding Cassette Transporter G2 (ABCG2) by AZ-628, a RAF Kinase InhibitorJing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, et al.
Cancers|February 23, 2020
Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer CellsJing-Quan Wang, Jonathan Y Li, Qiu-Xu Teng, et al.
Frontiers in Oncology|July 17, 2020
Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer CellsWeiguo Feng, Meng Zhang, Zhuo-Xun Wu, et al.
Frontiers in Oncology|July 6, 2019
Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an <i>in vitro</i> StudyNing Ji, Yuqi Yang, Chao-Yun Cai, et al.
Frontiers in Oncology|August 15, 2020
NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug ResistanceMeng Zhang, Xuan-Yu Chen, Xing-Duo Dong, et al.
Cancer Communications (London, England)|June 12, 2020
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitorYuqi Yang, Ning Ji, Chao-Yun Cai, et al.
Frontiers in Pharmacology|March 14, 2022
Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer CellsXing-Duo Dong, Meng Zhang, Chao-Yun Cai, et al.
Pageof 5